E Fund Management’s Coherus Oncology CHRS Stock Holding History

E Fund Management’s Portfolio CHRS Stock Details CHRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-45,010	Closed	-$168K	–	312
2023 Q3	$168K	Buy	+45,010	New	+$208K	0.01%	266
2023 Q2	–	Sell	-22,741	Closed	-$156K	–	313
2023 Q1	$156K	Sell	22,741 -1,846	-8%	-$14.3K	0.01%	310
2022 Q4	$195K	Buy	24,587 +6,114	+33%	+$47K	0.02%	307
2022 Q3	$178K	Sell	18,473 -7,517	-29%	-$76.1K	0.02%	312
2022 Q2	$188K	Buy	25,990 +12,504	+93%	+$109K	0.02%	305
2022 Q1	$174K	Buy	+13,486	New	+$171K	0.01%	304

Other funds holding CHRS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

E Fund Management's CHRS Position: Q4 2023 in Review

E Fund Management sold out of Coherus Oncology (CHRS) in Q4 2023, closing a stake of 45,010 shares — an estimated $168K sold.

E Fund Management first reported a position in CHRS in Q1 2022 and held it in 6 quarters. The position peaked at $195K in Q4 2022. 156 funds tracked by Wall St. Rank hold CHRS as of Q4 2023.

E Fund Management reported no remaining Coherus Oncology position as of Q4 2023 after selling out during the quarter.
E Fund Management sold 45,010 Coherus Oncology shares in Q4 2023, an estimated $168K.
E Fund Management first reported a position in Coherus Oncology in Q1 2022 and held it in 6 quarters.
E Fund Management's Coherus Oncology position peaked at $195K in Q4 2022.
156 funds tracked by Wall St. Rank held Coherus Oncology as of Q4 2023.

Based on E Fund Management's 13F filing for Q4 2023, filed 7 Feb 2024.